<b><i>Introduction:</i></b> There have been few studies comparing younger and older adults with membranous nephropathy. The objective of this study was to compare younger and older patients with membranous nephropathy, in terms of the clinical, etiological, remission, and survival data. <b><i>Method:</i></b> This was a retrospective study of patients with membranous nephropathy who underwent renal biopsy between 2009 and 2017. <b><i>Results:</i></b> We included 214 patients with membranous nephropathy. At diagnosis, 169 (79%) of those patients were &#x3c;60 years of age and 45 (21%) were ≥60 years of age. There was a predominance of males in both groups. The degree of proteinuria and the prevalence of hematuria did not differ significantly between the groups. However, the median serum creatinine level was higher in the ≥60-year group as was the prevalence of hypertension. Of the patients evaluated, 36 (16.8%) had secondary membranous nephropathy. Although the proportions of infectious and autoimmune causes were comparable between the two groups, neoplastic etiologies were more common in the ≥60-year group. A total of 86 in the &#x3c;60-year group and 25 in the ≥60-year group were followed long term, and partial or complete remission was achieved in 68.5% and 68.0% of the younger and older patients, respectively. However, whom progressed to requiring dialysis eight (9.3%) were in the &#x3c;60-year group patients and eight (32.0%) of the ≥60-year group patients (<i>p</i> = 0.0045). <b><i>Conclusion:</i></b> Despite having worse renal function at diagnosis, older patients with membranous nephropathy appear to have remission rates comparable to those of younger patients with the disease, which demonstrates the benefits of seeking diagnosis and treatment.